Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Bone Marrow and Kidney Transplantation for Multiple Myeloma and ESRD
NCT02158052Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2015
- Primary completion
- Jun 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of haploidentical bone marrow transplant (Centre Hospitalier Intercommunal Creteil) in multiple myeloma (MM), amyloid light chain amyloidosis and end stage renal disease (ESRD) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Number of Participants Without Renal Allograft Rejection at 6 months. Started Feb 2015; status: completed.
02
Drugs
haploidentical bone marrow transplant (Centre Hospitalier Intercommunal Creteil)
03
Conditions
multiple myeloma (MM)amyloid light chain amyloidosisend stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02158052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02158052.